Outline-Key Concepts 12-12

Outline-Key Concepts 12-12 - Outline & Key Concepts:...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon
I. Breast Cancer a. Medicalizing Prevention i. SERMS: Selective Estrogen Receptor Modulators 1. Tamoxifen (Nolvadex) a. Breast Cancer Prevention Trial b. Important questions/considerations 2. Raloxifene (Evista) ii. Phytoestrogens b. Treatments i. Surgery 1. Mastectomy: a. Radical b. Modified 2. Lumpectomy ii. Radiation iii. Chemotherapy c. Think Before You Pink! II. a. Direct to Consumer Ads: Background i. Previously limited to two types of DTC ads: 1. Health seeking ads 2. Reminder ads ii. FDA Modernization Act of 1997 iii. Immideate increase in ads, 24 more drugs advertised on tv iv. 96’ $791 millions spent on DTC ads; 2001, 2.7 billion b. Issues and Debates around Ads i. Proponents arguments 1. They argue that these ads are for consumer get info that they wouldn’t already have 2. Increase doctor and patient interaction, doctor needs to prescribe these drugs 3. All ads=brand name reason to use, increase
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Image of page 2
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 03/27/2008 for the course WOMENS STU 104 taught by Professor N/a during the Fall '08 term at Wisconsin.

Page1 / 2

Outline-Key Concepts 12-12 - Outline & Key Concepts:...

This preview shows document pages 1 - 2. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online